Your Cart ( 3 Items )

Error: 500: HTTP/2 500
• A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis
  August 2018 | Volume 17 | Issue 8 | | 888 | Copyright © August 2018
  Boni E. Elewski MD,^a Leon H. Kircik MD,^b Nathan Stasko PhD,^c Emily De Leon MSCR,^c Carolyn Enloe MPH,^c Todd Durham PhD,^c Tomoko Maeda-Chubachi MD^c
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• CLINICAL TRIAL REVIEWS
  March 2005 | Volume 4 | Issue 2 | | 254 | Copyright © March 2005
  
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Efficacy and Safety of Toreforant, a Selective Histamine H4 Receptor Antagonist, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Trial
  August 2018 | Volume 17 | Issue 8 | | 873 | Copyright © August 2018
  Ellen Frankel MD,^a Michael Song MD,^b Shu Li PhD,^b Jingzhi Jiang MS,^b Robin L. Thurmond PhD,^c Bruce Randazzo MD PhD^c,d
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs